Share on StockTwits

Imprivata’s (NASDAQ:IMPR) quiet period will end on Monday, August 4th. Imprivata had issued 5,000,000 shares in its public offering on June 25th, AmericanBankingNews.com reports. The total size of the offering was $75,000,000 based on an initial share price of $15.00. During Imprivata’s quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Several analysts have recently commented on the stock. Analysts at Wells Fargo & Co. initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an “outperform” rating on the stock. Separately, analysts at William Blair initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an “outperform” rating on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an “overweight” rating and a $19.00 price target on the stock.

Shares of Imprivata (NASDAQ:IMPR) traded down 0.21% on Friday, hitting $14.47. 73,992 shares of the company’s stock traded hands. Imprivata has a 1-year low of $13.30 and a 1-year high of $17.49. The stock has a 50-day moving average of $15.87 and a 200-day moving average of $15.87. The company’s market cap is $330.1 million.

Imprivata Inc is a provider of authentication and access management technology solutions for the healthcare industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.